5 things to know before the stock market opens on Monday

Here are five key things investors need to know to start the trading day:

Stocks are off a sluggish start to the month, as futures along with major indexes slipped on Monday. S&P 500 futures fell 0.5%, Nasdaq-100 futures fell 0.6% and Dow Jones Industrial Average futures fell 0.4%. A surge in U.S. Treasury yields and higher oil prices weighed on futures last week after modest gains in the first few days of the month's trading. Follow live market updates.

Here comes the Q3 report. With the next earnings season starting this week pepsico, Delta Air Lines, JP Morgan Chase And Wells Fargo Set to issue quarterly updates. The Federal Reserve should now provide banks with some insight into expectations of a low interest rate environment, while consumer names like Pepsi and Delta will shed light on Americans' spending habits in the final few months of the year. Here are the times each report is due:

• Tuesday: PepsiCo (before hours)
• Thursday: Delta Air Lines (before hours)
• Friday: JP Morgan Chase (before hours), Wells Fargo (before hours)

Pack your parachutes, looks like the Feds might be calling off the elusive soft landing. Friday's jobs data blew Wall Street expectations out of the water, adding 254,000 jobs to the labor market – more than 100,000 above consensus. CNBC Economics Editor Jeff Cox reports that this extraordinary gain has brought the US economy out of the shadow of recession. US Bank chief economist Beth Ann Bovino said, “We were expecting a softer landing. This gives us more confidence that it appears to be in place.” “It also raises the possibility of no-landing, which means stronger economic data for 2025 than we currently expect.”

The pharmaceutical giant Pfizer It has an active investor in its waiting room. Starboard Value has acquired a nearly $1 billion stake in the company and is looking to make a turnaround, CNBC's Rohan Goswami reports. Activists believe Pfizer's current leadership, led by CEO Albert Borla, has deviated from a historically disciplined cost structure and investment in innovative drugs, according to people familiar with the matter. The correct plan to starboard could not be learned. Pfizer is attempting its own rebound after sales of its Covid vaccine fell, as well as revenue and stock prices fell after pandemic-era demand fell.

“Joker: Folie à Deux”, the second installment of the blockbuster franchise, had a disappointing debut weekend at the box office. The film grossed just $40 million in its opening weekend, less than half of its predecessor “Joker's” opening in 2019. Adding insult to injury, the sequel's budget was triple that of the original. ComScore Senior Media Analyst Paul Dargarbedian said, “The creative risks that 'Joker: Follies a Deux' took are admirable, but mixed moviegoer response to very tough critical reviews as well as a challenging marketplace environment. The string of recent sequels at the box office will continue next year: Hollywood's Filmmakers bank on existing IP based on built-in audiences to drive more than half of ticket sales for films slated for 2025 from major studios.

– CNBC's Lisa Kailai Hahn, Jesse Pound, Jeff Cox, Rohan Goswami and Sarah Whitten contributed to this report.